BioShin
Latest round
- Series A
Last raised
- Sep 2020
Total raised
- $60M
Investors
- 5
About BioShin
Founded in 2019 and based in Shanghai, China, BioShin Limited is a biopharmaceutical company. The company is affiliated with Biohaven Pharmaceutical Holding Company Ltd. The company's main products include drugs targeting neurological and neuropsychiatric disorders. It has a calcitonin gene-related peptide (CGRP) receptor antagonist and glutamate modulator platform.
Who invested in BioShin
5 investors across 1 round
See all investors in BioShin
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 25, 2020
Amount
$60M
Investors
Questions about BioShin
Who invested in BioShin?
BioShin has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioShin raised?
BioShin has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioShin last raise money?
BioShin's most recent round on record is a Series A, in Sep 2020.
What does BioShin do?
Founded in 2019 and based in Shanghai, China, BioShin Limited is a biopharmaceutical company.
Where is BioShin headquartered?
BioShin is headquartered in Shanghai, China.
Which VCs invest in companies like BioShin?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at BioShin's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like BioShin? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.